Lombard Medical, Inc. acquired Altura Medical, Inc. from New Leaf Venture Partners, L.L.C., Advanced Technology Ventures, SV Life Sciences Fund IV, backed by SV Life Sciences Advisers, LLC and others for $49 million.
July 30, 2015
Share
Lombard Medical, Inc. (NasdaqGM:EVAR) acquired Altura Medical, Inc. from New Leaf Venture Partners, L.L.C., Advanced Technology Ventures, SV Life Sciences Fund IV, backed by SV Life Sciences Advisers, LLC and others for $49 million in stock on July 30, 2015. Under the terms of the agreement, Lombard Medical will issue 3.75 million shares of its common stock subject to certain lock up conditions, as consideration and assume $5.5 million in bank debt and $2.5 million in certain liabilities and transaction-related costs. In addition, up to $27.5 million may be paid based on the achievement of certain commercial and regulatory milestones anticipated over the next five years, which, Lombard has the option to pay in either cash or stock. Matthew H Clawson and Susan Heins of Pure Communications and Simon Conway and Victoria Foster Mitchell of FTI Consulting acted as PR advisors for Lombard Medical.
Lombard Medical, Inc. (NasdaqGM:EVAR) completed the acquisition of Altura Medical, Inc. from New Leaf Venture Partners, L.L.C., Advanced Technology Ventures, SV Life Sciences Fund IV, backed by SV Life Sciences Advisers, LLC and others on July 30, 2015.
Lombard Medical, Inc. is a medical device company. The Company is focused solely on the minimally invasive treatment of aortic disease. The Company partners with MicroPort Endovastec to offer Minos abdominal aortic aneurysm (AAA) stent-graft, the Hercules TAA stent graft and the Castor Branched Thoracic stent graft, in addition to its own Aorfix and Altura stent grafts. The Companyâs products include Minos, Aorfix, Altura, Meridian, Hercules, Castor, and Hercules Balloon.
Lombard Medical, Inc. acquired Altura Medical, Inc. from New Leaf Venture Partners, L.L.C., Advanced Technology Ventures, SV Life Sciences Fund IV, backed by SV Life Sciences Advisers, LLC and others for $49 million.
LOMBARD MEDICAL, INC. 
